Documentation Centre

 

 

  of 67 Next page

Go to page: of

Screenshot Date Categories Title Author Format
What additional pragmatic large nutritional trial would you like to conduct? What would be your priority question? October 11, 2017 What additional pragmatic large nutritional trial would you like to conduct? What would be your priority question? Frank M. Sacks, MD, FAHA, Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, United States Expert Opinions
Video 1:24 min.
(7 MB)
Mitigating cardiovascular risk in type 2 diabetes with antidiabetes drugs: A review of principal cardiovascular outcome results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 trials. Diabetes Care. 2017;40:821-831 October 09, 2017 Mitigating cardiovascular risk in type 2 diabetes with antidiabetes drugs: A review of principal cardiovascular outcome results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 trials. Diabetes Care. 2017;40:821-831 Kaul S Key Publications
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389:2226-2237 September 29, 2017 Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389:2226-2237 Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Weber MA, Williams B, Yusuf S Key Publications
Target blood pressure in patients at high cardiovascular risk. Lancet. 2017;389:2170-2172 September 29, 2017 Target blood pressure in patients at high cardiovascular risk. Lancet. 2017;389:2170-2172 Kahan T. Key Publications
Effects of sugar-sweetened beverage consumption on microvascular and macrovascular function in a healthy population. Arterioscler Thromb Vasc Biol. 2017;37:1250-1260 September 21, 2017 Effects of sugar-sweetened beverage consumption on microvascular and macrovascular function in a healthy population. Arterioscler Thromb Vasc Biol. 2017;37:1250-1260 Loader J, Meziat C, Watts R, Lorenzen C, Sigaudo-Roussel D, Stewart S, Reboul C, Meyer G, Walther G Key Publications
Sugar-sweetened beverage and vascular function: Not so sweet after all. Arterioscler Thromb Vasc Biol. 2017;37:1020-1021 September 21, 2017 Sugar-sweetened beverage and vascular function: Not so sweet after all. Arterioscler Thromb Vasc Biol. 2017;37:1020-1021 Shah PK Key Publications
Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial. Atherosclerosis. 2017;261:12-18 September 18, 2017 Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial. Atherosclerosis. 2017;261:12-18 Nicholls SJ, Ray KK, Ballantyne CM, Beacham LA, Miller DL, Ruotolo G, Nissen SE, Riesmeyer JS; ACCENTUATE Investigators Key Publications
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering. Nat Rev Cardiol. 2017;14:319-320 September 15, 2017 Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering. Nat Rev Cardiol. 2017;14:319-320 Shapiro MD, Fazio S Key Publications
Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME. Nat Rev Endocrinol. 2017;13:365-374 September 14, 2017 Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME. Nat Rev Endocrinol. 2017;13:365-374 Sarafidis PA, Lazaridis AA, Ruiz-Hurtado G, Ruilope LM Key Publications
Dietary quality changes in response to a sugar-sweetened beverage-reduction intervention: results from the Talking Health randomized controlled clinical trial. Am J Clin Nutr. 2017;105:824-833 September 08, 2017 Dietary quality changes in response to a sugar-sweetened beverage-reduction intervention: results from the Talking Health randomized controlled clinical trial. Am J Clin Nutr. 2017;105:824-833 Hedrick VE, Davy BM, You W, Porter KJ, Estabrooks PA, Zoellner JM Key Publications

  of 67 Next page

Go to page: of